Pacific Biosciences Q3 Revenue Slightly Beats Expectations
Pacific Biosciences' third-quarter revenue slightly exceeded expectations; the headline cites adoption of SPRQ-Nx.
Pacific Biosciences' third-quarter revenue slightly exceeded expectations; the headline cites adoption of SPRQ-Nx.